Sloan-Kettering Cancer Center Memorial, 10% Owner at Actinium Pharmaceuticals, Inc. (ATNM), sold 21,990 shares at $1.80 ($40K) on 2016-07-08, disclosed to the SEC on 2016-07-12.
Open-market sale of $40k ATNM by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.80 | 21,190 | $38K | 96.4% |
| 2 | $1.80 | 800 | $1K | 3.6% |
| Total | $1.80 avg | 21,990 | $40K | 100% |
| Filing → |
| ATNM | SELL | 2016-08-17 | $17K | — | Filing → |
| ATNM | SELL | 2016-07-14 | $6K | — | Filing → |
| ATNM | SELL | 2016-07-07 | $38K | — | Filing → |